Trial Search Results

Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung Disease

Primary ciliary dyskinesia (PCD), also known as Kartagener syndrome, is a genetic disorder of the cilia, which are microscopic hair-like cells. Cilia work to keep the respiratory system clean by moving mucus that contains debris to the large airways, where it can be coughed out. People with PCD have cilia that do not move properly and therefore are not effective in cleaning the respiratory system. This study will determine when PCD starts and how it changes over time, specifically in terms of how well the lungs work, what germs grow in lung secretions, and how the lungs look on computed tomography (CT) scans.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborator: National Heart, Lung, and Blood Institute (NHLBI)

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   - Younger than 5 years of age

   - Diagnosis of PCD or probable PCD based on criteria listed above

   - Parent or legal guardian willing to give informed consent

Exclusion Criteria:

   - Unable to attend follow-up appointments

   - History of lung transplant

   - Any co-existing severe diseases that may have significant impact on lung function,
   respiratory infections, or overall health status (i.e., severe congenital heart
   disease, severe scoliosis, AIDS, cancer, or end-stage kidney disease)

Ages Eligible for Study

N/A - 4 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting